HC Wainwright & Co. Reiterates Buy on X4 Pharmaceuticals, Maintains $5 Price Target
X4 PHARMACEUTICALS INC +2.88% Pre
X4 PHARMACEUTICALS INC XFOR | 0.50 0.50 | +2.88% 0.00% Pre |
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates X4 Pharmaceuticals (NASDAQ:
XFOR) with a Buy and maintains $5 price target.